Viemed Healthcare (VMD) Capital Expenditures (QoQ) (2018 - 2026)
Viemed Healthcare (VMD) Capital Expenditures (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240.59% |
| Dec 31, 2025 | 74.66% |
| Sep 30, 2025 | -194.25% |
| Jun 30, 2025 | 451.37% |
| Mar 31, 2025 | 114.53% |
| Dec 31, 2024 | -207.43% |
| Sep 30, 2024 | 7,717.17% |
| Jun 30, 2024 | -87.77% |
| Mar 31, 2024 | 114.48% |
| Dec 31, 2023 | -207.23% |
| Sep 30, 2023 | 825.52% |
| Jun 30, 2023 | -146.04% |
| Mar 31, 2023 | 682.78% |
| Dec 31, 2022 | 105.51% |
| Sep 30, 2022 | -199.62% |
| Jun 30, 2022 | 10,789.00% |
| Sep 30, 2021 | 133.33% |
| Jun 30, 2021 | -200.00% |
| Mar 31, 2021 | 123.72% |
| Dec 31, 2020 | -406.06% |